Subscribe To

Price Alert Latest News Economic Calendar News

BPTH / Bio-Path Holdings to Announce Fourth Quarter and Full Year 2022 Financial Results on March 31, 2023

HOUSTON, March 24, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Friday, March 31, 2023 at 8:30 a.m. ET to report financial results for the fourth quarter and full year ended December 31, 2022 and to provide a business overview. Read More

Demo Live Account See Partner Details

Content Topics

Bio

Path

Holdings

Announce

Fourth

Quarter

Full

Year

2022

Bio path

Financial

Results

Stock

BPTH

Posted: Mar 24 2023, 16:01

Author Name: GlobeNewsWire

BPTH News

By GlobeNewsWire
September 8, 2023

Bio-Path Holdings to Present at H.C. Wainwright 25th Annual Global Investment Conference

HOUSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® lip

By Seeking Alpha
August 15, 2023

Bio-Path Holdings, Inc. (BPTH) Q2 2023 Earnings Call Transcript

Bio-Path Holdings, Inc. (NASDAQ:BPTH ) Q2 2023 Results Conference Call August 15, 2023 8:30 AM ET Company Participants Will O'Connor - Investor Relati

By InvestorPlace
June 26, 2023

Why Is Bio-Path (BPTH) Stock Down 12% Today?

Bio-Path (NASDAQ: BPTH ) stock is sliding lower on Monday after the company announced a proposed public share offering. Bio-Path has yet to reveal the

By Seeking Alpha
May 12, 2023

Bio-Path Holdings, Inc. (BPTH) Q1 2023 Earnings Call Transcript

Bio-Path Holdings, Inc. (NASDAQ:BPTH ) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ET Company Participants Will O'Connor - Investor Relation

By GlobeNewsWire
March 24, 2023

Bio-Path Holdings to Announce Fourth Quarter and Full Year 2022 Financial Results on March 31, 2023

HOUSTON, March 24, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® ant

By GlobeNewsWire
August 9, 2022

Bio-Path Holdings to Announce Second Quarter 2022 Financial Results on August 16, 2022

HOUSTON, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® anti

By Seeking Alpha
May 17, 2022

Bio Path Holdings Inc. (BPTH) CEO Peter Nielsen on Q1 2022 Results - Earnings Call Transcript

Bio Path Holdings Inc. (NASDAQ:BPTH ) Q1 2022 Results Conference Call May 17, 2022 8:30 AM ET Company Participants Peter Nielsen - President, CEO Anth

By Benzinga
April 12, 2022

Why Bio-Path Holdings Shares Are Rising After Hours

Bio-Path Holdings Inc (NASDAQ: BPTH) shares are trading higher in Tuesday's after-hours session following the company's BP1003 data presentation at

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.